Login/Sign Up
Viflunate 0.05% Eye Drop
₹126*
MRP ₹140
10% off
₹119*
MRP ₹140
15% CB
₹21 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Viflunate 0.05% Eye Drop belongs to the class of ocular medications called ‘topical corticosteroids’ used to treat inflammatory conditions after eye surgery. It is effectively used to treat eye inflammation caused by allergies, iritis (inflammation of the coloured part of the eye (iris)), uveitis (inflammation of the middle layer of the eye (uvea)), eye injury, postinfectious pain and inflammation.
Viflunate 0.05% Eye Drop contains Difluprednate, a topical corticosteroid with anti-inflammatory properties and acts by inhibiting the chemicals such as prostaglandins production (chemical messengers) that make the eye red, swollen and itchy. It is used to treat post-operative eye pain and inflammation.
Viflunate 0.05% Eye Drop is for ophthalmic (use in the eyes) use only. Use Viflunate 0.05% Eye Drop as prescribed by your doctor. You are advised to use Viflunate 0.05% Eye Drop for as long as your doctor has prescribed it based on your medical condition. You may experience watery eyes, irritation, eye itching, and eyes more sensitivity to light in some cases. Most of these side effects of Viflunate 0.05% Eye Drop are temporary, do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Do not use Viflunate 0.05% Eye Drop without consulting your doctor if you have a damaged cornea, ulcers in the eye, eye infection producing pus, open lesions in the eye and glaucoma (a condition where the pressure inside the eye increases). Inform your doctor if you are pregnant or breastfeeding before using Viflunate 0.05% Eye Drop. If you wear contact lenses, remove them before using Viflunate 0.05% Eye Drop, and you can put it back 15 minutes after using Viflunate 0.05% Eye Drop. Avoid touching the eyedropper with bare hands or taking it closer to the eyelids while administering drops since it contaminates the dropper tip and solution. If you wear contact lenses, please inform your doctor.
Viflunate 0.05% Eye Drop contains Difluprednate used to treat post-operative eye pain and inflammation. Viflunate 0.05% Eye Drop is a topical corticosteroid with anti-inflammatory properties and acts by inhibiting the chemicals such as prostaglandins production (chemical messengers) that make the eye red, swollen and itchy. Viflunate 0.05% Eye Drop is also used to treat post-infectious swelling and pain of the eyes, treat anterior uveitis, and inflammation that affects the front part of the eye.
Do not take Viflunate 0.05% Eye Drop if you are allergic or have had a severe reaction to the corticosteroids or any of the ingredients of Viflunate 0.05% Eye Drop. Please inform your doctor if you are pregnant or breastfeeding before starting Viflunate 0.05% Eye Drop. Viflunate 0.05% Eye Drop is not recommended for children below 1 year of age as the safety and effectiveness have not been established. Do not stop taking Viflunate 0.05% Eye Drop even if you feel better without asking your doctor, as your symptoms may come back and even worsen your condition. To avoid any contamination, avoid touching the tip of the dropper. Do not put in other eye medication simultaneously; wait for at least 15 minutes before putting in the second medication. If you have had glaucoma (increased eye pressure), herpes simplex infection, or any other eye problem, do not take Viflunate 0.05% Eye Drop until prescribed by your doctor. Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve and defects in visual acuity and fields of vision. Do not use eye drops for longer than recommended by your doctor as they may suppress adrenal gland function and may increase the risk of cataracts (clouding of the eye) and also increases the risk of a second infection.
Drug-drug interactions: Viflunate 0.05% Eye Drop may interact with a smallpox vaccine.
Drug-food interactions: No interactions found.
Drug-disease interactions: Viflunate 0.05% Eye Drop should not be used in patients with fungal infections, viral infections such as herpes simplex or varicella or parasitic infections such as amoebiasis, tuberculosis, damaged cornea, ulceration and glaucoma (increased pressure inside the eye).
Endophthalmitis: Endophthalmitis is the medical term for significant inflammation within the eye. It can happen after some type of eye surgery or if the eye is penetrated by an external item. People with glaucoma surgery (such as glaucoma filtering) or cataract surgery are at life-long risk of getting endophthalmitis. Eye pain that intensifies following surgery or injury to the eye, as well as diminished or loss of vision, are symptoms. Anterior uveitis is an inflammation of the middle layer of the eye, including the iris and adjacent tissue, known as the ciliary body.
Alcohol
Caution
is best to avoid alcohol while taking medication. Viflunate 0.05% Eye Drop makes you dehydrated and affects eye pressure.
Pregnancy
Caution
Viflunate 0.05% Eye Drop is a pregnancy Category C medicine. It is not known whether Viflunate 0.05% Eye Drop can be used in pregnancy. Please consult your doctor. Your doctor will prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
It is unknown if Viflunate 0.05% Eye Drop passes into breastmilk. Consult your doctor before taking Viflunate 0.05% Eye Drop if you are breastfeeding.
Driving
Caution
Viflunate 0.05% Eye Drop may cause vision problems. However, it will be mild and temporary. So, avoid driving until your vision clears.
Liver
Safe if prescribed
Viflunate 0.05% Eye Drop can be used for treating eye infections in patients with liver diseases.
Kidney
Safe if prescribed
Viflunate 0.05% Eye Drop can be used for treating eye infections in patients with kidney diseases.
Children
Caution
Please consult your doctor if Viflunate 0.05% Eye Drop is to be used in children. Safety and effectiveness in pediatric patients have not been established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes